Prognostic value of 0-(2-[18F]-fluoroethyl)-L-tyrosine PET in patients with recurrent glioblastoma.

Geens, W. (Speaker), Du Four, S. (Contributor), S VAN LAERE (Contributor), Schwarze, J. K. (Contributor), Awada, G. (Contributor), Bruneau, M. (Contributor), Tijtgat, J. (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor), Duerinck, J. (Contributor)